Meloxicam vs Ibuprofen for Acute Pain
For acute pain management, ibuprofen is the preferred first-line NSAID over meloxicam due to its superior GI safety profile, faster onset of action, more flexible dosing intervals, and lower cost, with meloxicam reserved primarily for chronic inflammatory conditions requiring once-daily dosing.
Key Dosing Differences
Ibuprofen:
- Acute pain: 400 mg every 4-6 hours as needed 1
- Maximum daily dose: 3200 mg 1
- Flexible dosing allows titration to pain severity
- Available over-the-counter at lower doses
Meloxicam:
- Standard dose: 7.5 mg once daily 2
- Maximum: 15 mg once daily 2, 3
- Once-daily dosing due to prolonged half-life
- Prescription-only medication
When Meloxicam May Be Preferred
While the evidence shows ibuprofen is generally superior for acute pain, meloxicam has specific advantages in limited scenarios:
- Chronic inflammatory conditions (osteoarthritis, rheumatoid arthritis) where once-daily dosing improves compliance 3
- Patients requiring sustained 24-hour coverage who cannot maintain multiple daily doses
- Selective COX-2 inhibition may theoretically reduce GI risk compared to non-selective NSAIDs, though clinical significance is debated 4
However, recent high-quality evidence challenges meloxicam's role in acute pain. A 2026 randomized trial found ibuprofen 400 mg every 8 hours produced lower pain scores than meloxicam 7.5 mg every 12 hours at nearly all time points after third molar surgery 5. Additionally, a 2025 study demonstrated that IV meloxicam led to increased opioid consumption and longer hospital stays compared to ketorolac in joint arthroplasty patients 6.
Contraindications (Shared)
Both medications share core NSAID contraindications 1:
- Known hypersensitivity to the specific drug
- History of asthma, urticaria, or allergic reactions to aspirin or other NSAIDs
- Perioperative period of CABG surgery
- Active GI bleeding or peptic ulcer disease
Critical Safety Considerations
GI Risk Stratification:
- Among non-selective NSAIDs, ibuprofen demonstrates superior GI safety compared to other agents 4
- Risk increases 4% per year with advancing age 4
- History of previous ulcer increases risk with odds ratio up to 13.5 4
- Concomitant anticoagulant use increases bleeding risk 5-6 fold 2
High-Risk Patients Requiring GI Protection: For patients with history of ulcers, age >75, or concurrent anticoagulation, combine any NSAID with a proton pump inhibitor 2, 4. The one-year bleeding risk ranges from 1 in 2,100 for adults <45 years to 1 in 110 for adults >75 years 2.
Cardiovascular Considerations: All NSAIDs carry cardiovascular risk. Use the lowest effective dose for the shortest duration 1. Meloxicam's prolonged half-life means sustained COX inhibition, which may have implications for patients with cardiovascular disease.
Common Pitfalls to Avoid
- Don't assume once-daily dosing is always better: For acute pain, the ability to titrate ibuprofen every 4-6 hours provides superior pain control
- Don't overlook cost: Generic ibuprofen costs $16-28/month for prescription doses versus $13-32/month for meloxicam 2, with OTC ibuprofen even cheaper
- Don't use meloxicam for rapid pain relief: Onset is slower than ibuprofen, making it suboptimal for acute breakthrough pain
- Don't exceed maximum doses: Ibuprofen >3200 mg/day or meloxicam >15 mg/day increases risk without additional benefit 1
Practical Algorithm
- For acute pain (dental procedures, minor injuries, dysmenorrhea): Start ibuprofen 400 mg every 4-6 hours 1, 5
- For chronic inflammatory conditions: Consider meloxicam 7.5 mg daily if once-daily dosing improves compliance 3
- For high GI risk patients: Add PPI regardless of NSAID choice; consider avoiding NSAIDs entirely if history of NSAID-related bleeding 2, 4
- Reassess after 48-72 hours: Both drugs should show therapeutic effect; if inadequate, consider alternative analgesic strategies rather than dose escalation
The evidence consistently favors ibuprofen for acute pain management, with meloxicam's role limited to specific chronic inflammatory conditions where once-daily dosing provides practical advantages.